XENON PHARMACEUTICALS INC. (XENE) ROI
- 2019-12-31: ROI -38.69%.
- 2019-09-30: ROI -43.10%.
- 2019-06-30: ROI -45.17%.
- 2018-03-31: ROI -76.16%.
Complete source-backed roi history.
- Available history
- 2017-12-31 to 2019-12-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2019-12-31 | -38.69% |
| 2019-09-30 | -43.10% |
| 2019-06-30 | -45.17% |
| 2018-03-31 | -76.16% |
| 2017-12-31 | -71.84% |
Annual ROI
| Date | ROI |
|---|---|
| 2019-12-31 | -38.69% |
| 2017-12-31 | -71.84% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |